CN101142208A - 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺 - Google Patents
作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺 Download PDFInfo
- Publication number
- CN101142208A CN101142208A CNA2006800085588A CN200680008558A CN101142208A CN 101142208 A CN101142208 A CN 101142208A CN A2006800085588 A CNA2006800085588 A CN A2006800085588A CN 200680008558 A CN200680008558 A CN 200680008558A CN 101142208 A CN101142208 A CN 101142208A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- sup
- group
- compound
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05102127 | 2005-03-17 | ||
EP05102127.7 | 2005-03-17 | ||
PCT/EP2006/060852 WO2006097534A1 (en) | 2005-03-17 | 2006-03-17 | 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101142208A true CN101142208A (zh) | 2008-03-12 |
CN101142208B CN101142208B (zh) | 2012-05-23 |
Family
ID=34939009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800085588A Active CN101142208B (zh) | 2005-03-17 | 2006-03-17 | 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺 |
Country Status (11)
Country | Link |
---|---|
US (1) | US7956196B2 (zh) |
EP (1) | EP1951704B1 (zh) |
JP (1) | JP5289934B2 (zh) |
CN (1) | CN101142208B (zh) |
AU (1) | AU2006224533B9 (zh) |
BR (1) | BRPI0606278B8 (zh) |
CA (1) | CA2600507C (zh) |
ES (1) | ES2574670T3 (zh) |
MX (1) | MX2007011292A (zh) |
RU (1) | RU2410382C2 (zh) |
WO (1) | WO2006097534A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110234635A (zh) * | 2016-09-14 | 2019-09-13 | 宇凤·简·曾 | 作为d-胺基酸氧化酶(daao)抑制剂之新颖经取代苯并咪唑衍生物 |
CN112638876A (zh) * | 2018-07-09 | 2021-04-09 | Abivax公司 | 用于治疗rna病毒感染的苯基/吡啶基-n-苯基/吡啶基衍生物 |
CN114423741A (zh) * | 2019-07-19 | 2022-04-29 | Abivax公司 | 用于治疗rna病毒感染的芳基-n-芳基衍生物 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007084728A2 (en) * | 2006-01-19 | 2007-07-26 | Abbott Laboratories | 2-imino-benzimidazoles |
JP5736318B2 (ja) * | 2008-12-08 | 2015-06-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌を治療するための化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4842875B1 (zh) * | 1969-01-29 | 1973-12-14 | ||
ATE258928T1 (de) | 1999-06-28 | 2004-02-15 | Janssen Pharmaceutica Nv | Respiratorisches syncytialvirus replikation inhibitoren |
AP1552A (en) | 1999-06-28 | 2006-01-17 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors. |
DE60033859T2 (de) * | 1999-06-28 | 2007-11-08 | Janssen Pharmaceutica N.V. | Hemmer des Respiratorischen Syncytial Virus |
-
2006
- 2006-03-17 AU AU2006224533A patent/AU2006224533B9/en not_active Ceased
- 2006-03-17 ES ES06708798.1T patent/ES2574670T3/es active Active
- 2006-03-17 MX MX2007011292A patent/MX2007011292A/es active IP Right Grant
- 2006-03-17 JP JP2008501332A patent/JP5289934B2/ja active Active
- 2006-03-17 RU RU2007138380/04A patent/RU2410382C2/ru active IP Right Revival
- 2006-03-17 EP EP06708798.1A patent/EP1951704B1/en active Active
- 2006-03-17 US US11/908,538 patent/US7956196B2/en active Active
- 2006-03-17 WO PCT/EP2006/060852 patent/WO2006097534A1/en active Application Filing
- 2006-03-17 CN CN2006800085588A patent/CN101142208B/zh active Active
- 2006-03-17 BR BRPI0606278A patent/BRPI0606278B8/pt not_active IP Right Cessation
- 2006-03-17 CA CA2600507A patent/CA2600507C/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110234635A (zh) * | 2016-09-14 | 2019-09-13 | 宇凤·简·曾 | 作为d-胺基酸氧化酶(daao)抑制剂之新颖经取代苯并咪唑衍生物 |
CN110234635B (zh) * | 2016-09-14 | 2023-03-10 | 宇凤·简·曾 | 作为d-胺基酸氧化酶(daao)抑制剂之新颖经取代苯并咪唑衍生物 |
CN112638876A (zh) * | 2018-07-09 | 2021-04-09 | Abivax公司 | 用于治疗rna病毒感染的苯基/吡啶基-n-苯基/吡啶基衍生物 |
US11739073B2 (en) | 2018-07-09 | 2023-08-29 | Abivax | Aryl-n-aryl derivatives for treating a RNA virus infection |
CN112638876B (zh) * | 2018-07-09 | 2023-12-26 | Abivax公司 | 用于治疗rna病毒感染的苯基/吡啶基-n-苯基/吡啶基衍生物 |
CN114423741A (zh) * | 2019-07-19 | 2022-04-29 | Abivax公司 | 用于治疗rna病毒感染的芳基-n-芳基衍生物 |
CN114423741B (zh) * | 2019-07-19 | 2023-11-07 | Abivax公司 | 用于治疗rna病毒感染的芳基-n-芳基衍生物 |
Also Published As
Publication number | Publication date |
---|---|
WO2006097534A1 (en) | 2006-09-21 |
CA2600507C (en) | 2013-10-22 |
RU2410382C2 (ru) | 2011-01-27 |
BRPI0606278B8 (pt) | 2021-05-25 |
ES2574670T3 (es) | 2016-06-21 |
AU2006224533B9 (en) | 2012-06-21 |
EP1951704B1 (en) | 2016-03-16 |
JP2008533103A (ja) | 2008-08-21 |
AU2006224533B2 (en) | 2012-05-03 |
MX2007011292A (es) | 2007-11-07 |
JP5289934B2 (ja) | 2013-09-11 |
US7956196B2 (en) | 2011-06-07 |
BRPI0606278A2 (pt) | 2009-06-09 |
US20080146564A1 (en) | 2008-06-19 |
AU2006224533A1 (en) | 2006-09-21 |
CN101142208B (zh) | 2012-05-23 |
RU2007138380A (ru) | 2009-04-27 |
BRPI0606278B1 (pt) | 2020-09-08 |
EP1951704A1 (en) | 2008-08-06 |
CA2600507A1 (en) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012080451A1 (en) | Imidazopyridines as respiratory syncytial virus antiviral agents | |
CN103313974A (zh) | 苯并咪唑呼吸道合胞病毒抑制剂 | |
KR101074333B1 (ko) | 호흡기 세포융합 바이러스 복제 저해제로서의아미노-벤즈이미다졸 유도체 | |
EP1896473B1 (en) | 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication | |
CN101142208B (zh) | 作为呼吸道合胞病毒复制抑制剂的1,3-二氢-苯并咪唑-2-亚基胺 | |
CN1918146B (zh) | 作为呼吸道合胞病毒复制抑制剂的氨基苯并咪唑和苯并咪唑 | |
CN101203506B (zh) | 杂环基氨基烷基取代的苯并咪唑 | |
JP2015522052A (ja) | 呼吸器合胞体ウイルス感染症の治療及び予防のための新規インダゾール | |
CN101203507B (zh) | 2-取代的苯并咪唑 | |
CN1894236B (zh) | 作为呼吸道合胞病毒复制抑制剂的氨基-苯并咪唑类衍生物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: JANSSEN R + D IRELAND Free format text: FORMER NAME: TIBOTEC PHARM LTD. Owner name: TIBOTEC PHARM LTD. Free format text: FORMER NAME: TIBOTEC NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Address after: The Irish Village Patentee after: TIBOTEC PHARMACEUTICALS Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150723 Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: JANSSEN R&D IRELAND |